Monday Mar 30, 2026
34 - Instant insights: HPV testing for cervical cancer screening (8 min)
Cervical cancer is the fourth most common cancer in women globally, and Human papilloma virus (HPV) causes nearly all cases. Laboratory screening can detect infection or abnormal cells early, so clinicians can intervene before cancer develops. Screening options include Pap testing, HPV testing, and co-testing, and guidelines recommendation different combinations of these tests based on age and clinical presentation.
This episode will
- Explain what HPV testing is and why HPV drives nearly all cervical cancers (1:00)
- Compare Pap testing, HPV testing, and co-testing (2:00)
- Summarize guideline-based screening options by age (3:30)
To learn more, please review the additional resources below for information on our cardiovascular, metabolic, endocrine, and wellness offerings as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.
Date: March 2026
Speaker(s): Maeson Latsko, PhD
Contributor(s): Maeson Latsko, PhD; Trisha Winchester, PhD, MBA; Pat Alagia, MD, MBA; Lisa Smith; Paula McCollem
Additional Resources
Quest Diagnostics Clinical Education Center [Link]
Quest Diagnostics Cervical Cancer Portfolio Brochure
ASCCP Management Guidelines Web Application
Ordering information:
ThinPrep Automated Test Code Aid
Age 21-29
Pap alone
ThinPrep® Automated Pap | Test Detail | Quest Diagnostics
Pap reflex to HPV DNA
Pap reflex to HPV mRNA
ThinPrep® Automated Pap with Reflex to HPV mRNA E6/E7 | Test Detail | Quest Diagnostics
Age 30-65
Pap and HPV DNA
Pap and HPV mRNA reflex to genotypes 16, 18/45
HPV Primary reflex to Pap
HPV Self-Collection
HPV DNA (16, 18, Other High Risk), PCR, Vaginal Self-Collected | Test Detail | Quest Diagnostics
No comments yet. Be the first to say something!